Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.
Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, Weisman M, Wallace DJ, Crues J, Khanna D, Eckel G, Yeilding N, Callegari P, Visvanathan S, Rojas J, Hegedus R, George L, Mamun K, Gilmer K, Troum O. Furst DE, et al. Among authors: hegedus r. Ann Rheum Dis. 2007 Jul;66(7):893-9. doi: 10.1136/ard.2006.068304. Epub 2007 Apr 5. Ann Rheum Dis. 2007. PMID: 17412737 Free PMC article. Clinical Trial.
A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis.
Huffstutter J, Craig WD, Schimizzi G, Harshbarger J, Lisse J, Kasle S, Hymson L, Yocum D, Castro L, Hegedus R, Callegari P, Yeilding N, Gilmer K. Huffstutter J, et al. Among authors: hegedus r. Curr Med Res Opin. 2007 Aug;23(8):1967-79. doi: 10.1185/030079907X210624. Curr Med Res Opin. 2007. PMID: 17626700 Clinical Trial.
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.
Keshavarzian A, Mayer L, Salzberg B, Garone M, Finkelstein W, Cappa J, Brand M, Hain J, Zelinger D, Hegedus R, Diamond RH, Campbell U, Lane C, Stang P, Watson J, Cominelli F. Keshavarzian A, et al. Among authors: hegedus r. Gastroenterol Hepatol (N Y). 2007 May;3(5):381-90. Gastroenterol Hepatol (N Y). 2007. PMID: 21960854 Free PMC article.
Directed Evolution-Driven Increase of Structural Plasticity Is a Prerequisite for Binding the Complement Lectin Pathway Blocking MASP-Inhibitor Peptides.
Dürvanger Z, Boros E, Nagy ZA, Hegedüs R, Megyeri M, Dobó J, Gál P, Schlosser G, Ángyán AF, Gáspári Z, Perczel A, Harmat V, Mező G, Menyhárd DK, Pál G. Dürvanger Z, et al. Among authors: hegedus r. ACS Chem Biol. 2022 Apr 15;17(4):969-986. doi: 10.1021/acschembio.2c00114. Epub 2022 Apr 4. ACS Chem Biol. 2022. PMID: 35378038 Free PMC article.
α -event characterization and rejection in point-contact HPGe detectors.
Arnquist IJ, Avignone FT 3rd, Barabash AS, Barton CJ, Bertrand FE, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Chan YD, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Drobizhev A, Edwards TR, Edwins DW, Edzards F, Efremenko Y, Elliott SR, Gilliss T, Giovanetti GK, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Hegedus RJ, Henning R, Aguilar DH, Hoppe EW, Hostiuc A, Kim I, Kouzes RT, Lopez AM, López-Castaño JM, Martin EL, Martin RD, Massarczyk R, Meijer SJ, Mertens S, Myslik J, Oli TK, Othman G, Pettus W, Poon AWP, Radford DC, Rager J, Reine AL, Rielage K, Ruof NW, Saykı B, Schönert S, Stortini MJ, Tedeschi D, Varner RL, Vasilyev S, Wilkerson JF, Willers M, Wiseman C, Xu W, Yu CH, Zhu BX. Arnquist IJ, et al. Among authors: hegedus rj. Eur Phys J C Part Fields. 2022;82(3):226. doi: 10.1140/epjc/s10052-022-10161-y. Epub 2022 Mar 15. Eur Phys J C Part Fields. 2022. PMID: 35310515 Free PMC article.
43 results